Caris Life Sciences Inc (STU:49J)
€ 13.6 -0.10 (-0.73%) Market Cap: 3.86 Bil Enterprise Value: 3.51 Bil PE Ratio: 0 PB Ratio: 7.40 GF Score: 17/100

Caris Life Sciences Inc at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 05:00PM GMT
Release Date Price: €13.9 (+2.96%)
Michael Ryskin
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Bobby Hill, Senior Vice President and C-CEO; and then finally, Luke Power, CFO from Caris. The recent the IPO-ed less than a year ago, and we'll have a presentation. If you have any questions towards the last two minutes, please raise your hand. We'll be happy to take them. Thank you for being here.

Robert Hill
Caris Life Sciences Inc - Senior Vice President and Co-CEO

Great. Well, thank you. This is our first conference here, actually, after many being public with our IPO last June, so it's a pleasure to be here. I think my main point that I'd like to just start out with is, although we've been at this since 2008 with our company, we're looking at opportunities in the marketplace that we think are more remarkable, facing our platform than we've ever seen.

We've been building this business since 2008. We got a very early look at multiomics with the Molecular Profile Institute. We launched, as you know, whole exome, whole transcriptome, 23,000 genes well in advance of anybody in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot